MIGRALIS F 10 TAB is a pharmaceutical formulation comprising Flunarizine 10 mg, a well-established calcium channel blocker used primarily for the prophylactic treatment of migraines. It is also beneficial in treating vestibular disorders, including chronic vertigo, dizziness, and Meniere's disease. The medication works by limiting the excessive influx of calcium ions into neuronal cells, which stabilizes neural transmission and improves blood flow to the brain. This action reduces the hyperexcitability associated with migraines and other neurologic imbalances.
MIGRALIS F 10 TAB is not intended to provide immediate relief during an acute migraine attack but is rather taken regularly to reduce the occurrence, intensity, and duration of migraine episodes over time. Its effects are most noticeable after consistent use for several weeks. Patients who suffer from migraines with or without aura often find significant improvement in quality of life with long-term Flunarizine therapy. It is also frequently prescribed in cases of chronic vertigo and motion sickness, where balance and inner ear function are compromised.
The recommended dosage for adults is typically 10 mg once daily, preferably at night to minimize drowsiness. In elderly patients, a reduced dosage of 5 mg may be advisable to limit the risk of excessive sedation. It is important that long-term use be monitored by a healthcare professional, especially in individuals with a history of depression or movement disorders, as rare cases of depressive symptoms or extrapyramidal side effects have been observed.
MIGRALIS F 10 TAB is developed and produced by Bluepill Express, a WHO-GMP certified third-party manufacturer with a strong presence in regulated and semi-regulated markets. The product undergoes rigorous quality testing at every stage of production and is compliant with global export requirements. Its packaging ensures product stability and is available in blister or alu-alu formats with multi-language labeling options for various export destinations.
This medication is designed for neurology-focused pharmaceutical markets and is suitable for hospitals, clinics, and pharmacies treating patients with chronic migraine and balance-related disorders. Bluepill Express ensures consistent batch quality, reliable supply chains, and the availability of complete documentation including Certificate of Analysis (COA), MSDS, stability studies, and product dossiers to support regulatory submissions.
Description provided by bluepill express.
FIEO Registered
Export Ready
